A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain
- 31 October 1992
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Pain and Symptom Management
- Vol. 7 (7), 393-399
- https://doi.org/10.1016/0885-3924(92)90018-d
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Analgesics in cancer pain: current practice and beliefsBritish Journal of Cancer, 1991
- Clinical observations on controlled-release morphine in cancer painJournal of Pain and Symptom Management, 1989
- Evaluation of a cancer pain model for the testing of long‐acting analgesics. The effect of ms contin in a double‐blind, randomized crossover designCancer, 1989
- Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patientsCancer, 1989
- The United States experience with oral controlled-release morphine (MS contin tablets).parts i and ii. review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjectsCancer, 1989
- A study of controlled-release oral morphine (Ms Contin) in an advanced cancer hospitalJournal of Pain and Symptom Management, 1987
- Controlled release morphine tablets: a double‐blind trial in patients with advanced cancerAnaesthesia, 1987
- Long-Acting Oral Morphine in Cancer Pain AnalgesiaThe Clinical Journal of Pain, 1987
- The Treatment of Cancer PainNew England Journal of Medicine, 1985
- Pain infirmity and psychotropic drugs in oncologyPain, 1978